ATE408827T1 - Quantifizierung von stressbelastung - Google Patents

Quantifizierung von stressbelastung

Info

Publication number
ATE408827T1
ATE408827T1 AT03810513T AT03810513T ATE408827T1 AT E408827 T1 ATE408827 T1 AT E408827T1 AT 03810513 T AT03810513 T AT 03810513T AT 03810513 T AT03810513 T AT 03810513T AT E408827 T1 ATE408827 T1 AT E408827T1
Authority
AT
Austria
Prior art keywords
stress
neutrophils
quantification
psychological
methodology
Prior art date
Application number
AT03810513T
Other languages
English (en)
Inventor
Rubina Mian
David Whyte Macdonald
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Innovation filed Critical Isis Innovation
Application granted granted Critical
Publication of ATE408827T1 publication Critical patent/ATE408827T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Ecology (AREA)
  • Physiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Holo Graphy (AREA)
AT03810513T 2002-11-06 2003-11-05 Quantifizierung von stressbelastung ATE408827T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0225885.3A GB0225885D0 (en) 2002-11-06 2002-11-06 Quantifying exposure to stress

Publications (1)

Publication Number Publication Date
ATE408827T1 true ATE408827T1 (de) 2008-10-15

Family

ID=9947318

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03810513T ATE408827T1 (de) 2002-11-06 2003-11-05 Quantifizierung von stressbelastung

Country Status (10)

Country Link
US (1) US7838262B2 (de)
EP (1) EP1558929B1 (de)
JP (1) JP4571864B2 (de)
AT (1) ATE408827T1 (de)
AU (1) AU2003276448A1 (de)
DE (1) DE60323661D1 (de)
DK (1) DK1558929T3 (de)
ES (1) ES2312854T3 (de)
GB (1) GB0225885D0 (de)
WO (1) WO2004042395A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201616640D0 (en) * 2016-09-30 2016-11-16 Sarphie David And Mian Rubina Monitoring cancer recurrence and progression
AU2020304536A1 (en) 2019-06-27 2022-01-06 Binary, Llc Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (POC) diagnostic testing point-of-care (POC) measurement of absolute neutrophil function (ANF)
JP2023554149A (ja) 2020-12-22 2023-12-26 セロクソ リミテッド 敗血症を診断およびモニターする方法
GB2619197A (en) 2021-02-02 2023-11-29 Seroxo Ltd Monitoring COVID-19 progression and treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401640A (en) * 1992-03-30 1995-03-28 Trustees Of Dartmouth College Method for enhancing detection of superoxide anion
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent
EP1262167A1 (de) * 2001-06-01 2002-12-04 Cognis France S.A. Kosmetische Zubereitungen enthaltend ein Extrakt von keimenden Pflanzen
BE1014949A3 (fr) * 2001-08-14 2004-07-06 Probiox Procede de detection de stress oxydant et trousse pour sa mise en oeuvre.
JP2007530574A (ja) * 2004-03-23 2007-11-01 ライフライン・ニュートラシューティカルズ・コーポレーション 哺乳動物において炎症及び酸化ストレスを軽減させるための組成物及び方法

Also Published As

Publication number Publication date
GB0225885D0 (en) 2002-12-11
JP4571864B2 (ja) 2010-10-27
EP1558929A1 (de) 2005-08-03
WO2004042395A1 (en) 2004-05-21
JP2006505263A (ja) 2006-02-16
EP1558929B1 (de) 2008-09-17
ES2312854T3 (es) 2009-03-01
DK1558929T3 (da) 2009-01-26
US20060014235A1 (en) 2006-01-19
US7838262B2 (en) 2010-11-23
AU2003276448A1 (en) 2004-06-07
DE60323661D1 (de) 2008-10-30

Similar Documents

Publication Publication Date Title
DE60228557D1 (de) Candida-nachweis
HK1070942A1 (en) Method for reducing effect of hematocrit on measurement of an analyte in whole blood, and test kit and test article useful in the method
EP1691192A4 (de) Blutbestandteilmessverfahren, dafür verwendeter sensor und messinstrument
EP1677097A4 (de) Verfahren und system zur bestimmung der konzentration eines fluoreszenzpigments
ATE514755T1 (de) Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung
AU2003228700A1 (en) Non-invasive substance concentration measurement using an optical bridge
EP1630562A4 (de) Dynamisches matrixempfindlichkeitsmessinstrument für interne sensoren und zugehöriges messverfahren
FI20011877A (fi) Menetelmä ja bioanturi analyysiä varten
WO2003066876A3 (en) An apparatus and methods for using biological material to discriminate an agent
DK2146209T3 (da) Neurodegenerative markører for Alzheimer's sygdom
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
MXPA05006382A (es) Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal.
NO20081343L (no) Biosensor-måleanordning, biosensor-målesystem og biosensor-målemetode
WO2004081521A3 (en) Methods for direct detection of individual methotrexate metabolites
DK1630527T3 (da) Optisk forskydningstransducer, forskydningsmålesystem og fremgangsmåde
ATE408827T1 (de) Quantifizierung von stressbelastung
WO2004113574A3 (en) Methods for disease screening
DK1604211T3 (da) Identifikation af terapeutiske forbindelser
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
WO2007075318A3 (en) Agents that reduce apoe-induced impairment of mitochondria and methods of use thereof
WO2004081535A3 (en) The establishment of proteome structure profile databases and their uses
DE112006001250A5 (de) Messgerät, Messverfahren, Messleitung und Elektrode
FI20011362A (fi) Röntgenfluoresenssianalysaattori ja menetelmä röntgenfluoresenssianalysaattorin käyttämiseksi
DK1257830T3 (da) Assay til måling af holo-transcobalamin og folat
FR2852096B1 (fr) Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1558929

Country of ref document: EP

EEIH Change in the person of patent owner